Lin JH - Search Results

1

Metabolic interactions between mibefradil and HMG-CoA reductase inhibitors: an in vitro investigation with human liver preparations.

Prueksaritanont T, Ma B, Tang C, Meng Y, Assang C, Lu P, Reider PJ, Lin JH, Baillie TA. Prueksaritanont T, et al. Among authors: lin jh. Br J Clin Pharmacol. 1999 Mar;47(3):291-8. doi: 10.1046/j.1365-2125.1999.00903.x. Br J Clin Pharmacol. 1999. PMID: 10215754 Free PMC article.

2

Mechanistic studies on metabolic interactions between gemfibrozil and statins.

Prueksaritanont T, Zhao JJ, Ma B, Roadcap BA, Tang C, Qiu Y, Liu L, Lin JH, Pearson PG, Baillie TA. Prueksaritanont T, et al. Among authors: lin jh. J Pharmacol Exp Ther. 2002 Jun;301(3):1042-51. doi: 10.1124/jpet.301.3.1042. J Pharmacol Exp Ther. 2002. PMID: 12023536

3

Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A.

Ma B, Prueksaritanont T, Lin JH. Ma B, et al. Among authors: lin jh. Drug Metab Dispos. 2000 Feb;28(2):125-30. Drug Metab Dispos. 2000. PMID: 10640508

4

Pharmacokinetics and interactions of a novel antagonist of chemokine receptor 5 (CCR5) with ritonavir in rats and monkeys: role of CYP3A and P-glycoprotein.

Kumar S, Kwei GY, Poon GK, Iliff SA, Wang Y, Chen Q, Franklin RB, Didolkar V, Wang RW, Yamazaki M, Chiu SH, Lin JH, Pearson PG, Baillie TA. Kumar S, et al. Among authors: lin jh. J Pharmacol Exp Ther. 2003 Mar;304(3):1161-71. doi: 10.1124/jpet.102.045096. J Pharmacol Exp Ther. 2003. PMID: 12604693

5

Interactions of human P-glycoprotein with simvastatin, simvastatin acid, and atorvastatin.

Hochman JH, Pudvah N, Qiu J, Yamazaki M, Tang C, Lin JH, Prueksaritanont T. Hochman JH, et al. Among authors: lin jh. Pharm Res. 2004 Sep;21(9):1686-91. doi: 10.1023/b:pham.0000041466.84653.8c. Pharm Res. 2004. PMID: 15497697

6

Complicating factors in safety testing of drug metabolites: kinetic differences between generated and preformed metabolites.

Prueksaritanont T, Lin JH, Baillie TA. Prueksaritanont T, et al. Among authors: lin jh. Toxicol Appl Pharmacol. 2006 Dec 1;217(2):143-52. doi: 10.1016/j.taap.2006.08.009. Epub 2006 Sep 1. Toxicol Appl Pharmacol. 2006. PMID: 17055014

7

Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization.

Prueksaritanont T, Subramanian R, Fang X, Ma B, Qiu Y, Lin JH, Pearson PG, Baillie TA. Prueksaritanont T, et al. Among authors: lin jh. Drug Metab Dispos. 2002 May;30(5):505-12. doi: 10.1124/dmd.30.5.505. Drug Metab Dispos. 2002. PMID: 11950779

8

Effects of fibrates on metabolism of statins in human hepatocytes.

Prueksaritanont T, Tang C, Qiu Y, Mu L, Subramanian R, Lin JH. Prueksaritanont T, et al. Among authors: lin jh. Drug Metab Dispos. 2002 Nov;30(11):1280-7. doi: 10.1124/dmd.30.11.1280. Drug Metab Dispos. 2002. PMID: 12386136

9

In vitro studies on the metabolic activation of the furanopyridine L-754,394, a highly potent and selective mechanism-based inhibitor of cytochrome P450 3A4.

Sahali-Sahly Y, Balani SK, Lin JH, Baillie TA. Sahali-Sahly Y, et al. Among authors: lin jh. Chem Res Toxicol. 1996 Sep;9(6):1007-12. doi: 10.1021/tx960060b. Chem Res Toxicol. 1996. PMID: 8870989

10

Interaction of diclofenac and quinidine in monkeys: stimulation of diclofenac metabolism.

Tang W, Stearns RA, Kwei GY, Iliff SA, Miller RR, Egan MA, Yu NX, Dean DC, Kumar S, Shou M, Lin JH, Baillie TA. Tang W, et al. Among authors: lin jh. J Pharmacol Exp Ther. 1999 Dec;291(3):1068-74. J Pharmacol Exp Ther. 1999. PMID: 10565826

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,021 results

Search Page

Filters